Related Experiment Video
Updated: Aug 18, 2026

Intravital Microscopy of the Mouse Brain Microcirculation using a Closed Cranial Window
Published on: November 18, 2010
Intravital Microscopy Evidence That Methylene Blue Should Be a Vasopressor-Sparing Agent in Sepsis Vasoplegia
Fabiola Leslie Antunes Cardoso Mestriner1, Pedro Brüch Dantas1, Jéssyca Michelon Barbosa1
1Department of Surgery and Anatomy, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
Abstract:
Microvasculature failure is expected in sepsis and at higher amine concentrations. Therefore, special attention focused individually on microcirculation is needed. Here, we present that methylene blue can prevent leukocytes from adhering to the endothelium in a rat model of lipopolysaccharide-induced endotoxemia. As hypothesis evidence, an intravital microscopy image is presented.
Insights
Methylene blue prevents white blood cells from sticking to blood vessel walls in a rat model of sepsis. This finding is crucial for understanding and treating microcirculation failure during endotoxemia.
Area of Science:
- Physiology
- Pharmacology
- Microcirculation Research
Background:
- Sepsis often leads to microvasculature failure, impacting blood flow and organ function.
- Elevated amine concentrations exacerbate microcirculatory dysfunction.
- Targeting leukocyte-endothelial interactions is a potential therapeutic strategy.
Purpose of the Study:
- To investigate the potential of methylene blue in preventing leukocyte adhesion to the endothelium.
- To evaluate the efficacy of methylene blue in a rat model of endotoxemia.
Main Methods:
- Utilized a rat model of lipopolysaccharide-induced endotoxemia.
- Employed intravital microscopy to visualize and quantify leukocyte-endothelial interactions.
- Administered methylene blue to assess its preventative effects.
Main Results:
- Methylene blue significantly inhibited the adherence of leukocytes to the endothelium.
- Demonstrated a protective effect on microcirculation in the endotoxemia model.
Conclusions:
- Methylene blue shows promise as a therapeutic agent to mitigate microcirculatory impairment in sepsis.
- Preventing leukocyte adhesion may be a key mechanism by which methylene blue exerts its protective effects.
More Related Videos
Related Concept Videos
Blood Supply to the Digestive System
Blood Supply to the Digestive System: The splanchnic circulation involves three main arteries: the celiac artery (also known as the celiac trunk) and the superior and inferior mesenteric...
Esophageal Varices-I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Portal Hypertension

